| 17.82 Delayed Data As of Jun 19 |  0.00 / 0.00%Today’s Change | 15.50 Today|||52-Week Range 21.95 | +5.95% Year-to-Date |
| Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Takeda Pharmaceutical C... Jun 03 / GlobeNewswirePNW - Paid Partner Content |
| Previous close | 17.82 |
| Today’s open | 17.33 |
| Day’s range | 17.33 - 17.84 |
| Volume | 1,156,930 |
| Average volume (3 months) | 2,271,160 |
| Market cap | $53.5B |
| Earnings growth (last year) | -52.61% |
| Earnings growth (this year) | -179.17% |
| Earnings growth (next 5 years) | +16.80% |
| Revenue growth (last year) | +18.39% |
| P/E ratio | 34.1 |
| Price/Sales | 2.08 |
| Price/Book | 1.14 |
| Today’s change | Today’s % change | |
|---|---|---|
| ZTSZoetis Inc | +1.68 | +1.47% |
| VRTXVertex Pharmaceutica... | +3.39 | +1.87% |
| CELGCelgene | +0.84 | +0.86% |
| AGNAllergan | +2.58 | +2.01% |
| Last reporting date | May 14, 2019 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $18.9B |
| Annual profit (last year) | $984.1M |
| Net profit margin | 5.20% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
President, CEO & Representative Director Christophe Weber |
Chief Financial Officer Costa Saroukos |
Corporate headquarters Osaka, Osaka |
